1,064 results on '"Compston, J."'
Search Results
102. Osteoporosis
103. The pathogenesis and investigation of metabolic bone disease
104. Management of male osteoporosis: report of the UK Consensus Group
105. Designer oestrogens: fact or fantasy?
106. Bone disease after liver transplantation should not be underestimated
107. Author's reply: Bone densitometry in clinical practice.
108. Fortnightly Review: Bone Densitometry in Clinical Practice.
109. Osteoporosis in severe congenital neutropenia treated with granulocyte colony-stimulating factor
110. Effect of Long Term Tamoxifen Treatment on Bone Turnover in Women with Breast Cancer.
111. Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science
112. Erratum to: Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw
113. Failure to Heal Vitamin D-Deficiency Rickets and Suppress Secondary Hyperparathyroidism with Conventional Doses of 1,25-Dihydroxy Vitamin D₃
114. Bone Density And Milk
115. Bone Densitometry In Clinical Practice
116. Bone Densitometry In Clinical Practice [with Reply]
117. Effect Of Tamoxifen On Bone [with Reply]
118. Preventing Osteoporosis
119. The Birth of JBMR Plus.
120. EFFECT OF CO-MORBIDITIES ON FRACTURE RISK: FINDINGS FROM THE GLOW STUDY
121. CONCERN ABOUT OSTEOPOROSIS IS ASSOCIATED WITH A WORST QUALITY OF LIFE IN UK WOMEN
122. ASSOCIATION BETWEEN FRACTURE SITE AND OBESITY IN MEN: A POPULATION-BASED STUDY
123. Erratum: Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (Maturitas (2013) 75 (392-396))
124. (PREMIER POSTER-AWARD CANDIDATE) CO-MORBIDITIES ASSOCIATED WITH FRACTURES IN POSTMENOPAUSAL WOMEN
125. Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013 (vol 75, pg 392, 2013)
126. DISEASE-SPECIFIC PERCEPTION OF FRACTURE RISK AND INCIDENT FRACTURE RATES AMONG POSTMENOPAUSAL WOMEN: THE GLOW REGISTRY
127. FRACTURE INCIDENCE IN OBESE POSTMENOPAUSAL WOMEN: THE GLOBAL STUDY OF OSTEOPOROSIS IN WOMEN (GLOW)
128. FAILURE TO PERCEIVE INCREASED RISK OF FRACTURE IN WOMEN 55 YEARS AND OLDER. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
129. DISTRIBUTION OF RISK FACTORS FOR FRACTURE IN WOMEN WITH AND WITHOUT A FRACTURE HISTORY: A REGIONAL COMPARISON. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
130. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons
131. The association between common vitamin D receptor gene variations and osteoporosis
132. GREES Recommendations for the Registration of New Drugs in the Prevention and Treatment of Osteoporosis
133. Mechanisms of bone loss in patients undergoing liver transplantation
134. Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK—an analysis of anonymous website activity
135. HIV infection and bone disease
136. Quality of life assessment in people living with and without HIV: UPBEAT study
137. Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015
138. Relationship between toluidine blue-stained calcification fronts and tetracycline-labeled surfaces in normal human iliac crest biopsies
139. Inter-observer and intra-observer variation in bone histomorphometry
140. 96-Week results of abacavir/lamivudine versus tenofovir/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study
141. Epidemiology and Economic Burden of Osteoporosis in Italy
142. Self-perception of fracture risk: what can it tell us?
143. THE ECONOMIC BURDEN OF FRACTURES IN THE EUROPEAN UNION IN 2010
144. Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women
145. Antidepressant medications and osteoporosis
146. Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. Executive Summary of the 2010 Position Development Conference on Interpretation and Use of FRAX® in Clinical Practice
147. FRACTURES IN OBESE POSTMENOPAUSAL WOMEN: PREVALENCE, SKELETAL LOCATION AND RISK FACTORS
148. Once-yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial
149. RISK FACTOR CHARACTERISTICS OF WOMEN WITH INCIDENT FRACTURES: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN
150. DEVELOPMENT AND VALIDATION OF AN EPIDEMIOLOGICAL MODEL TO ESTIMATE THE BURDEN OF POST-MENOPAUSAL OSTEOPOROSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.